As XRP ETF speculation heats up and court deadlines loom, XRP outperforms peers. Will SEC actions and legal rulings drive ...

XRP remains in legal limbo as court deadlines near. ETF hopes support sentiment, but appeal risks could trigger price ...

The past few days have been tough for the overall crypto industry, which has experienced a downward movement. Amid this drop, Ripple (XRP) has been on the decline and has fallen over 3% in the past ...

On-chain data shows Ripple whales are quietly moving capital into Unilabs Finance, just as XRP’s price prediction cools. So why are they shifting focus?The answ ...

RXS, the Rexas Finance token, is quickly finding its way to the radar of investors who are looking at a huge upside by 2025.

Ethereum ETFs hit $837.5 million in inflows, signaling rising institutional interest. Can Pectra upgrade sustain the momentum?

XRP price target set at $5.45 as trader holding 1.8 million tokens plans a patient long-term strategy to turn his investment ...

Explore the latest XRP prediction, PEPE’s bullish comeback, and how Unstaked’s $9.2M raise in stage 19 positions it as one of ...

XRP faces bearish signals and legal uncertainty, but whales buying 190M tokens and ETF optimism hint at potential recovery.

Sarepta Therapeutics (NasdaqGS:SRPT) saw its share price rise by 19% over the past month, a move that notably outpaced the broader market's 1% increase for the week and the 13% gain over the year.